Cytogenetic aspects of adult primary myelodysplastic syndromes: Clinical implications

This publication has 89 references indexed in Scilit:

• Pathobiology, classification, and diagnosis of myelodysplastic syndrome
  Best Practice & Research Clinical Haematology, 2004
• The myelodysplastic syndrome(s): a perspective and review highlighting current controversies
  Leukemia Research, 2002
• Molecular cytogenetic aspects of hematological malignancies: Clinical implications
  American Journal of Medical Genetics, 2002
• The cytogenetics of myelodysplastic syndromes
  Best Practice & Research Clinical Haematology, 2001
• Mutations With Loss of Heterozygosity of p53 Are Common in Therapy-Related Myelodysplasia and Acute Myeloid Leukemia After Exposure to Alkylating Agents and Significantly Associated With Deletion or Loss of 5q, a Complex Karyotype, and a Poor Prognosis
  Journal of Clinical Oncology, 2001
• Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: Experience from the Copenhagen series updated to 180 consecutive cases
  Genes, Chromosomes and Cancer, 1998
• RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up
  Leukemia, 1998
• Epidemiological and Etiological Aspects of Myelodysplastic Syndromes
  Leukemia & Lymphoma, 1995
• N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome
  Blood, 1993
• Multiple chromosomally distinct cell populations in myelodysplastic syndromes and their possible significance in the evolution of the disease
  British Journal of Haematology, 1986